A new molecular defect in the lecithin: cholesterol acyltransferase (LCAT) gene associated with fish eye disease.
We report a new genetic defect in the lecithin:cholesterol acyltransferase (LCAT) gene associated with classical clinical and biochemical features of fish eye disease. The 63-year-old Australian female proband also suffers from non-insulin-dependent (type II) diabetes mellitus. She presented with co...
Main Authors: | C Contacos, D R Sullivan, K A Rye, H Funke, G Assmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1996-01-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520376331 |
Similar Items
-
The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes
by: J A Kuivenhoven, et al.
Published: (1997-02-01) -
Lecithin:cholesterol acyltransferase (LCAT) mass; its relationship to LCAT activity and cholesterol esterification rate.
by: J J Albers, et al.
Published: (1981-11-01) -
Protein and cell therapy for lecithin-cholesterol acyltransferase (LCAT) deficiency
by: Low, J. K.
Published: (2009) -
Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease
by: Berlinda Vanloo, et al.
Published: (2000-05-01) -
Attempts to generate atheroprotective lecithin-cholesterol acyltransferase (LCAT) phenotypes by chimeraplasty
by: Sperber, Galia
Published: (2006)